FDA Budget Request Reminds Congress: OTC Rulemakings Take Time
This article was originally published in The Tan Sheet
Executive Summary
In its fiscal 2017 budget proposal, FDA responds to House and Senate appropriators' questions included in their reports on the agency's fiscal 2016 appropriation. Appropriators question why FDA has not approved additional OTC sunscreen active ingredients since Congress passed the Sunscreen Innovation Act in 2014.
You may also be interested in...
Draft Guidance Drills Down With Details To Cut Pediatric Acetaminophen Overdose Risk
FDA suggests new and repeats previous recommendations to reduce the risk of pediatric overdose with acetaminophen products due either to unsupervised ingestion or therapeutic errors. The guidance includes greater detail on delivery devices and labeling information for pediatric acetaminophen OTCs.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.